The treatment for infected wounds


(57) Abstract:

The invention relates to medicine and can be used to enhance antibacterial activity and expansion of the spectrum of antibacterial action. Antibacterial contains streptocid and nitrosol as polymer - monoalkyl ether glycol and the primary fatty alcohols of the formula C18H37O(C2H4O)20(preparation of OS-20), as a two - component solvent mixture of 1,2-propylene glycol and water, and optionally contains vaseline oil and primary alcohols fatty fraction C16-C21formula CnH2n+1HE, where n = 16 and 21, with the following ratio of components, wt.% streptocid 4 - 6; nitazol 1 - 3; vaseline oil 10 - 30; preparation of OS-20 of 1.2 - 1.6; primary alcohols fatty fraction C16-C216,4 - 6,8; 1,2-propylene glycol 20-40; water - the rest. Good and satisfactory effect is obtained from 90,9% of patients. 3 table.

The invention relates to medicine, in particular to the surgery and the result they have proved.

Closest to the claimed is an antibacterial drug for the topical treatment of wounds - ointment mafenide acetate, which according to its chemical structure namenda acetate prepared on a hydrophilic base, containing polymer is a polyethylene oxide mol.m. 1500 and mixed two-component solvent consisting of polyethylene oxide mol.m. 400, and distilled water.

The composition of the ointment. wt. %: Mafenide acetate 10.0 polyethylene oxide-1500 40.0 polyethylene oxide-400 34,5 distilled Water 15.0 Sodium sulfate 0,5

However, the ointment mafenide acetate has the disadvantages associated with low antibacterial activity of the main active substances, consequently, it is necessary to apply very high concentration of 10%. As a result, when applying the ointment on the burn or wound surface patients are effects local irritation, pain, burning, causing the necessity of prescription analgesics. For these reasons, 10% ointment mafenide acetate is unsuitable for application to large areas: wounds and burns.

The aim of the invention is the enhancement of antibacterial activity and expansion of the spectrum of antibacterial action.

This goal is achieved by the fact that medicine as an antibacterial substances contains streptocid and nitazolom as polymer - monoalkyl ether glycol and the primary fatty alcohols of the formula C18H3716-C21formulanH2n+1HE, where n = 16-21, with the following ratios, wt. %: Streptocid 4-6 Nitazol 1-3 vaseline Oil 10-30 Drug OS-20 1,2-1,6 primary Alcohols, grease - ing fraction16-C216,4-6,8 1,2-Propylene glycol 20-40 distilled Water To 100

P R I m e R 1. The tool contains, %: Streptocid 4-6 Nitazol 1-3 vaseline Oil 10-30 Drug OS-20 1,2-2,0 primary Alcohols fatty fraction16-C216,8-6,0 1,2-propylene glycol 20-40 distilled Water To 100

The composition was prepared as follows. At a temperature of 75aboutWith vaseline oil floated the preparation of OS-20 and the primary alcohols of the fatty fraction16-C21and poured with stirring, heated to the same temperature water (by weight). Was emulsiable turbomaschinen, cooling the emulsion to 45aboutC. In 1,2-propylene glycol (or vaseline oil) using a rotary pulsation apparatus was dispersively streptocid and nitazol so that the temperature of the suspension does not exceed 45aboutC. the Suspension with stirring, poured into the emulsion and the resulting mixture was cooled to 25aboutWith the continued parameterarray activity of the compounds was determined by the method of diffusion in agar with respect to the reference strains of bacteria, recommended by who and obtained from gisk named after.L.A. Tarasevich, and freshly isolated bacteria strains from patients with infected wounds.

In table. 1 shows the antibacterial activity of compounds 1-9, prototype - ointment mafenide acetate 10% and analogues (liniment of streptocide 5% and suspensions nitazola 2%) against Pseudomonas aeruginosa.

The combined use of streptocide and nitazola with such components in such proportions leads to unexpected synergistic effect of character - a strong antibacterial action against Pseudomonas aeruginosa.

In table.2 shows information about zones delays the growth of bacteria optimal composition 2 and prototype - ointment mafenide acetate 10%.

As is seen in table.2 data on the effects on Pseudomonas aeruginosa inventive composition effectively ointments mafenide acetate. Its advantage lies in the significantly higher zones of growth inhibition of other pyogenic bacteria (Staphylococcus, E. coli, clostridia), and in the case of asporogenic anaerobic-peptococcus and bacteroids.

For part 2 were highly sensitive in 98% of cases (49 strains of 50) viewed the diversified processes, who have MDR to antibiotics.

As can be seen from the data presented in table.3, the inventive composition 2 on the effectiveness of antibacterial action significantly outperform their counterparts - ointment polioksidony and gentamitsinovoy, which in most cases, Pseudomonas aeruginosa and Staphylococcus were not sensitive. Ointment of levocin containing the antibiotic chloramphenicol and sulfadimetoksin comparable with the composition 2 performance impact on staphylococci and less effective against Pseudomonas aeruginosa.

The study of therapeutic properties of composition 2 on animals carried out in a series of model experiments on rabbits of the chinchilla breed by weight of 2,5-3,0 kg

The treatment composition 2 was started on day 7 after infection, i.e., after the stage of hyperemia and education inflammatory infiltrate. The abscess was opened, if it has not been opened spontaneously and produced primary surgical processing of wounds. Bleeding was stopped by 3% hydrogen peroxide solution and applied a bandage with part 2 called stratonica. The amount of fungicide applied daily to the wound, amounted to 5-10 g

Below are the dynamics of the flow of pus is e infected animals bacteria: the wounds 4x4 - 5x6 cm, around the edges of wounds hyperemic edematous skin edges of wounds nekrotizirovanne; wounds filled with viscous blue-green purulent contents. Made of surgical treatment of wounds. Imposed headbands with stratonicea. Inoculation of pus and esecanna necrotic tissue revealed Pseudomonas aeruginosa in the amount of 108-10101 g of tissue.

1st day after treatment of animals: the wounds 4x4 - 5x6 cm; redness and swelling of the underlying tissue decreased; the wound edges and some parts of the wound depth infiltrated, there is necrotic tissue, pus viscous, blue-green. Produced debridement. The bandage was applied with stratonicea. When planting necrotic tissue revealed Pseudomonas aeruginosa in the amount of 106-108microbial cells in 1 g of tissue.

the day 3 after treatment animals: rabbits active, good appetite. The wounds 3x4 - 4x4 see a Weak pus. Change bandages. Sowing tissues revealed Pseudomonas aeruginosa in the amount of 103-1051,

5th day after treatment of animals: the wounds are dry, their size 3-4 cm along the edges of the wound pink granulation. Only in the depth of the wound serous secretion. Change bandages with stratonicea. Sowing tissue izadi after treatment of animals: wounds the size of 2-3 cm dry, covered with a crust; the entire surface wounds covered with pink granulation; the edges of wounds observed epithelialization. Change bandages with stratonicea. When sowing tissue from the wound revealed a single colony of Escherichia coli.

10 days after treatment animals: wounds dry; kapitalizirovana on a large surface area. Pseudomonas aeruginosa from fabrics not planted.

Thus, the claimed composition does not lose its activity when heavyline and exhibits antibacterial properties in experiments in vivo, reducing the level of bacterial contamination of the wound already to the third day of treatment 5 orders of magnitude. On the 5th day of treatment of microbial infection of wounds by Pseudomonas aeruginosa becomes below a critical level of development of inflammatory process (1051 g of tissue), and by the 7th-10th day she wound almost no planted.

The proposed antibacterial agent in the form of ointments can improve the effectiveness of treatment of purulent-inflammatory processes caused by Escherichia coli in the form of monocultures and in multicomponent associations with obligate and facultative anaerobes, which are resistant to antibiotics. It can be used on the sociology for the prevention and treatment of purulent complications.

FOR the TREATMENT of INFECTED wounds, containing an antibacterial substance and a hydrophilic ointment base, characterized in that as an antibacterial substances it contains streptocid and nitazol and the base contains liquid paraffin, drug OS-20 (monoalkyl ether glycol and the primary fatty alcohols of the formula C18H37(C2H4O)20the primary fatty alcohols fraction16- C21formula CnH2n+1OH , where n is 16 - 21, 1,2-propylene glycol and water in the following ratio, wt.%

Streptocide 4 - 6

Nitazol 1 - 3

Liquid paraffin 10 - 30

Preparation of OS-20 of 1.2 - 1.6

The primary fatty alcohols fraction16- C21the specified formula 6,4 - 6,8

1,2-propylene glycol 20 - 40

Water The Rest


Same patents:

The invention relates to medicine, in particular to the surgery and the result they have proved

The invention relates to 7-examinerlawrence heterocyclic Amida - analogues of prostaglandins, which are receptor antagonists AND thromboxane a2(THA2or combined receptor antagonists AND thromboxane a2(thromboxane synthetase inhibitors, and are used, for example, in the treatment of thrombotic disease and/or vascular spasm: have a long duration of action

The invention relates to a new di-tert-butylaniline derivative used for the treatment of inflammatory processes, as well as caused by ischemia cell damage

The invention relates to medicine, in particular to the surgery and the result they have proved
The invention relates to medicine

The invention relates to medicine, in particular to intensive therapy for the treatment of traumatic and hemorrhagic shock

The invention relates to the field of medicine and relates to an anti-inflammatory composition and method of its production

The invention relates to medicine, in particular to the surgery and the result they have proved

FIELD: medicine; pharmaceutical engineering.

SUBSTANCE: pharmaceutical composition COMPRISES 5-(2-pyrazinyl)-4-methyl-1,2-dithyol -3-thion (oltipraze) and dimethyl-4,4'-dimetoxi-5,6,5',6'-dimethylene-dioxybiphenyl-2,2' dicarboxilate (DDB) as the main components. Oltipraze: DDB proportion is preferentially equal to 50-1:1-50, the most preferential being 5:1.

EFFECT: enhanced effectiveness of treatment.

6 cl, 6 dwg, 9 tbl

FIELD: medicine.

SUBSTANCE: the present innovation deals with antiviral preparations that contain aliphatic alcohol C21-C28 in combination with either nucleoside or nucleotide analog or phosphoformic acid in pharmaceutically acceptable carrier. It is necessary to mention that n-docosanol is considered to be a preferable aliphatic alcohol. Concentration of aliphatic alcohol C21-C28 corresponds to 0.05% to 40% by weight. Concentration of either nucleoside or nucleotide analog or phosphoformic acid corresponds to 0.1% to 10% by weight. The innovation, also, deals with the ways to treat viral infections due to applying such compositions. Aliphatic alcohols C21-C28 synergistically intensify antiviral activity of nucleoside analogs directed against replication of several herpetic viruses and that of cow's pox.

EFFECT: higher efficiency of inhibition.

28 cl, 13 dwg, 21 ex, 6 tbl

FIELD: medicine, obstetrics, gynecology, mammology.

SUBSTANCE: method involves administration of alcohol-air mixture into cyst cavity wherein the amount of air and alcohol is similar and represents 40-60% of the content volume evacuated from the cyst cavity. Invention promotes to prophylaxis of diseases relapses and prevention of iatrogenic complications associated with carrying out this procedure. Invention can be used for treatment of patients with cystic mactopathy.

EFFECT: improved method for treatment.

2 tbl

FIELD: thoracic surgery and pulmonology.

SUBSTANCE: method comprises complex therapy utilizing ecdysterone-containing preparation, namely 0.005-0.01% ecdysterone solution prepared by dissolving ecdysterone in mixture of equal portions of 70% alcoholic tinctures of calendula and eucalyptus. Preparation is administered orally in dose of 30-40 drops before meal.

EFFECT: activated formation of antibodies, function of phagocytes and T cells, protein synthesis processes, including surfactant synthesis, and stabilized alveolocyte membranes.

2 ex

FIELD: medicine.

SUBSTANCE: the present innovation should be fulfilled due to performing sclerotherapy with 96%-ethanol under ultrasound control at the dosage of 0.5-1 ml/ml of nodal volume in case of nodal neoplasms and 3-5 ml in case of cystic neoplasm after liquid aspiration. Moreover, a day before each course of sclerotherapy one should introduce Movalis for 5-10 d once daily after meals. The course of sclerotherapy should be started with introducing 96%-ethanol, then 8-10 d later it is necessary to introduce benzyl peniccilin sodium salt at the dosage of 0.5-1 ml/ml of nodal volume in case of nodal neoplasm, and 0.5 ml after liquid aspiration - in case of cystic neoplasm. The innovation enables to decrease side manifestations of complex therapy performed due to decreasing the quantity of injections.

EFFECT: higher efficiency of therapy.

1 cl, 4 ex

FIELD: medicine, proctology.

SUBSTANCE: the present innovation deals with introducing a sclerosing preparation consisting of equal parts of 96% alcohol and 2% lidocain at the quantity of 2-4 ml, for all fissures it is necessary to inject 10 ml 0.5%-novocain solution and 2 ml solcoseryl or actovegin, then one should change the direction to move a needle towards coccyx towards sphincter's external diameter to introduce 5 ml 0.5%-Novocain solution and, not shifting a needle, one should introduce a sclerosing preparation. The innovation enables to conduct simultaneously the following procedures: anesthesia, the rupture of adhesions, blocking painful and sensitive branches of pudendal nerve that innervate ulcerous area that leads then to decreased pain syndrome, decreased sphincter's spasm and better ulcer's healing.

EFFECT: higher efficiency of sclerotherapy.

2 dwg, 2 ex

FIELD: medicine.

SUBSTANCE: claimed agent contains as active ingredient quarternary ammonium compound and/or N,N-bis(3-aminopropyl)-dodecylamine and/or polyhexamethylene guanidine derivative; non-ionic surfactant, alcohol, urea, synthetic C12-C14- or C10-C16-fatty acid alkylamides; chelator, as well as dye, odorant, and water in specific ratio (mass %).

EFFECT: environmentally friendly anti-infective agent of high antimicrobial action, excellent washing properties and high effectiveness in low concentration.

3 tbl, 13 ex, 3 cl

FIELD: organic chemistry, pesticides.

SUBSTANCE: claimed composition represents mixture of carvacrol and thymol compounds with salt of transition metal, namely zinc, wherein carvacrol and thymol compound/zinc ratio is from 60:40 to 65:35. Also described is pesticide composition containing mixture of carvacrol and thymol compounds with salt of transition metal, namely zinc, and at least one carrier, wherein weight ratio of carvacrol to thymol is 10:1. Claimed method for parasite controlling includes step of composition blending with carrier and application thereof onto target area.

EFFECT: composition for pest controlling and prevention of contamination with pests such as insect, mite, fungi or parasites.

FIELD: medicine, pharmacy.

SUBSTANCE: invention relates to ointment used in treatment of scars by external using on a patient body. Ointment for treatment of scars comprises wax, vegetable oil, heparin, lydaze, glycerol and dimethylsulfoxide in the following ratio of components per 100 g: wax, 13-15 g; heparin, 5000-10000 U; lydaze, 64-128 U; dimethylsulfoxide, 10-15 ml; glycerol, 10-15 ml, and vegetable oil, the balance. Invention provides enhancing effectiveness in treatment of patients and the absence of adverse complications.

EFFECT: improved, enhanced and valuable medicinal properties of ointment.

1 tbl, 3 ex

FIELD: medicine, ophthalmology.

SUBSTANCE: the present innovation deals with medicinal treatment of ischemic variant of primary glaucoma in case of stable normalization of intraocular pressure (IOP) in patients with myopic refraction. For this purpose, it is necessary to carry out electromagnetic impact successively onto cerebral orbital, temporal and occipital areas, carotid sinuses of cervical autonomic plexus, and, also, one should additionally inject gliatilin per 1.0 in combination with instillations of 0.5%-betaxolol solution per 2 drops twice daily into ocular conjunctival cavity. Therapy should last for 10 d at repeating the course once or twice annually. The method provides stable normalization of IOP, improves cerebral and orbital hemodynamics and stabilization of visual functions.

EFFECT: higher efficiency of therapy.

1 ex, 5 tbl